Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study

Autor: Salles, Gilles *, Duell, Johannes, González Barca, Eva, Tournilhac, Olivier, Jurczak, Wojciech, Liberati, Anna Marina, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, André, Marc, Kalakonda, Nagesh, Dreyling, Martin, Weirather, Johannes, Dirnberger-Hertweck, Maren, Ambarkhane, Sumeet, Fingerle-Rowson, Günter, Maddocks, Kami
Zdroj: In The Lancet Oncology July 2020 21(7):978-988
Databáze: ScienceDirect